Produkt kostenlos erhalten?
Für Ihre Validierungsdaten erstatten wir Ihnen den vollen Kaufpreis. Ich möchte dieses Produkt validieren
General |
|
---|---|
Antigen | Chemokine (C-C Motif) Ligand 5 (CCL5) Antikörper |
Reaktivität | Human Alternativen |
Wirt | Maus Alternativen |
Klonalität (Klon) | |
Konjugat | Dieser CCL5 Antikörper ist unkonjugiert Alternativen |
Applikation |
Biochemical Assay (BCA)
Alternativen
|
![]() |
1 Publikation vorhanden |
Hersteller | Anmelden zum Anzeigen |
Produktdetails anti-CCL5 AntikörperTarget Details CCL5 Anwendungsinformationen Handhabung Referenzen für anti-CCL5 Antikörper (ABIN2664007) Bilder |
|
Reinigung | This antibody was purified by affinity chromatography. |
Klon | BL-5030 |
Isotyp | IgG1 kappa |
Target Details CCL5Produktdetails anti-CCL5 Antikörper Anwendungsinformationen Handhabung Referenzen für anti-CCL5 Antikörper (ABIN2664007) Bilder zurück nach oben |
|
Antigen | |
Andere Bezeichnung | RANTES (CCL5 Antibody Abstract) |
Hintergrund | RANTES is a 7.8 kD member of the CC family of chemokines, also known as CCL5, which is expressed in T cells and monocytes/macrophages. RANTES is strongly chemotactic for monocytes/macrophages, memory T cells, eosinophils, and induces histamine release from basophils. In solution, RANTES can form high molecular weight aggregates that exhibit dissimilar biological activities to the dimeric form. Aggregates cause T cell and neutrophil activation while promoting HIV infection, whereas, the dimeric form exhibits RANTES-induced chemotaxis and inhibits HIV infection. Interestingly, as T cells become activated RANTES secretion appears to decrease. |
Pathways | Cellular Response to Molecule of Bacterial Origin, Regulation of G-Protein Coupled Receptor Protein Signaling, Smooth Muscle Cell Migration |
AnwendungsinformationenProduktdetails anti-CCL5 Antikörper Target Details CCL5 Handhabung Referenzen für anti-CCL5 Antikörper (ABIN2664007) Bilder zurück nach oben |
|
Applikationshinweise | Optimal working dilution should be determined by the investigator. |
Beschränkungen | Nur für Forschungszwecke einsetzbar |
HandhabungProduktdetails anti-CCL5 Antikörper Target Details CCL5 Anwendungsinformationen Referenzen für anti-CCL5 Antikörper (ABIN2664007) Bilder zurück nach oben |
|
Konzentration | 0.5 mg/mL |
Buffer | Phosphate-buffered solution, pH 7.2, containing 0.09 % Sodium azide. |
Lagerung | 4 °C |
Informationen zur Lagerung | The antibody solution should be stored undiluted between 2°C and 8°C. |
Referenzen für anti-CCL5 Antikörper (ABIN2664007)Produktdetails anti-CCL5 Antikörper Target Details CCL5 Anwendungsinformationen Handhabung Bilder zurück nach oben |
|
Allgemeine Veröffentlichungen |
Brown, Zurawski, Mosmann, Zurawski et al.: "A family of small inducible proteins secreted by leukocytes are members of a new superfamily that includes leukocyte and fibroblast-derived inflammatory agents, growth factors, and indicators of ..." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 142, Issue 2, pp. 679-87, 1989 |